Global proteome analysis of hepatitis B virus expressing human hepatoblastoma cell line HepG2

Journal of Medical Virology

Volumn 81, Issue 9, 2009, Pages 1539-1550

  Huang, Qingling ^a   Wang, Lin ^a   Bai, Shiyu ^a   Lin, Wansong ^a   Chen, Wannan ^a   Lin, Jianyin ^a   Lin, Xu ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

2 DE; DIGE; Hepatitis B virus; Proteome analyses

Indexed keywords

CELL CYCLE PROTEIN; PROTEOME;

ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL STRAIN HEPG2; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TWO DIMENSIONAL GEL ELECTROPHORESIS; VIRUS GENOME; VIRUS REPLICATION;

CELL LINE, TUMOR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; PROTEOME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; VIRAL PROTEINS;

HEPATITIS B VIRUS;

EID: 68949160963     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21593     Document Type: Article

References (31)

1. Belt PB, Groeneveld H, Teubel WJ, van de Putte P, Backendorf C. 1989. Construction and properties of an Epstein-Barr-virus-derived cDNA expression vector for human cells. Gene 84:407-417. (Pubitemid 20043787)
2. Boyle JS, Brady JL, Lew AM. 1998. Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Nature 392:408-411.
3. Chuang WL, Chang WY, Lu SN, Su WP, Lin ZY, Chen SC, Hsieh MY, Wang LY, You SL, Chen CJ. 1992. The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. A case-control study. Cancer 69:2052-2054.
4. Conejero-Goldberg C, Tornatore C, Abi-Saab W, Monaco MC, Dillon- Carter O, Vawter M, Elsworth J, Freed W. 2000. Transduction of human GAD67 cDNA into immortalized striatal cell lines using an Epstein-Barr Virus-based plasmid vector increases GABA content. Exp Neurol 161:453-461. (Pubitemid 30137005)
5. Eggermont J, Proudfoot NJ. 1993. Poly(A) signals and transcriptional pause sites combine to prevent interference between RNA polymerase II promoters. EMBO J 12:2539-2548. (Pubitemid 23194205)
6. Erhardt JA, Hynicka W, DiBenedetto A. 1998. A novel F Box protein, NFB42, is highly enriched in neurons and induces growth arrest. J Biol Chem 273:35222-35227. (Pubitemid 29028228)
7. Foo NC, Ahn BY,Ma X, Hyun W, Yen TS. 2002. Cellular vacuolization and apoptosis induced by hepatitis B virus large surface protein. Hepatology 36:1400-1406. (Pubitemid 35403531)
8. Fujii K, Kondo T, Yokoo H, Okano T, Yamada M, Yamada T, Iwatsuki K, Hirohashi S. 2006a. Database of two-dimensional polyacrylamide gel electrophoresis of proteins labeled with CyDyeDIGEFluor saturation dye. Proteomics 6:640-1653.
9. Fujii R, Zhu C, Wen Y, Marusawa H, Bailly-Maitre B, Matsuzawa S, Zhang H, Kim Y, Bennett CF, Jiang W, Reed JC. 2006b. HBXIP, cellular target of Hepatitis B Virus oncoprotein, is a regulator of centrosome dynamics and cytokinesis. Cancer Res 66:9099-9107. (Pubitemid 44521129)
10. Görg A, Obermaier C, Boguth G, Csordas A, Diaz JJ, Madjar JJ. 1997. Very alkaline immobilized pH gradients for two-dimensional electrophoresis of ribosomal and nuclear proteins. Electrophoresis 18:328-337. (Pubitemid 27174416)
11. Günther S, Li BC, Miska S,Krü ger DH, Meisel H, Will H. 1995. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol 69:5437-5444.
12. Inui A, Sogo T, Komatsu H, Miyakawa H, Fujisawa T. 2005. Antibodies against cytokeratin8/18 in a patient with de novo autoimmune hepatitis after living-donor liver transplantation. Liver Transpl 11:504-507. (Pubitemid 40704061)
13. Jiang J, Nilsson-Ehle P, Xu N. 2006. Influence of liver cancer on lipid and lipoprotein metabolism. Lipids Health Dis 5:4.
14. Kalchman MA, Graham RK, Xia G, Koide HB, Hodgson JG, Graham KC, Goldberg YP, Gietz RD, Pickart CM, Hayden MR. 1996. Huntingtin is ubiquitinated and interacts with a specific ubiquitinconjugating enzyme. J Biol Chem 271:19385-19394.
15. Kobayashi T, Tanaka K, Inoue K, Kakizuka A. 2002. Functional ATPase activity of p97/valosin-containing protein is required for the quality control of endoplasmic reticulum in neuronally differentiated mammalian PC12 cells. J Biol Chem 277:47358-47365. (Pubitemid 36159250)
16. Konishi H, Nakagawa T, Harano T, Mizuno K, Saito H, Masuda A, Matsuda H, Osada H, Takahashi T. 2002. Identification of frequent G2 checkpoint impairment and a homozygous deletion of 14-3-3e at 17p13.3 in small cell lung cancers. Cancer Res 62:271-276. (Pubitemid 34074014)
17. Lin X, Yuan ZH, Wu L, Ding JP, Wen YM. 2001. A single amino acid in the reverse transcriptase domain of hepatitis B virus affects virus replication efficiency. J Virol 75:11827-11833. (Pubitemid 33063274)
18. Lin X, Ma ZM, Yao X, Zhang YP, Wen YM. 2002. Replication efficiency and sequence analysis of full-length hepatitis B virus isolates from hepatocellular carcinoma tissues. Int J Cancer 102: 487-491. (Pubitemid 35316003)
19. Newberry EP, Xie Y, Kennedy SM, Luo JY, Davidson NO. 2006. Protection against western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice. Hepatology 44:1191-1205.
20. Norton PA, Gong Q, Mehta AS, Lu X, Block TM. 2003. Hepatitis B virus-mediated changes of apolipoprotein mRNA abundance in cultured hepatoma cells. J Virol 77:5503-5506. (Pubitemid 36460964)
21. Park SG, Jung GH. 2001. Human hepatitis B virus polymerase interacts with the molecular chaperonin Hsp60. J Virol 75:6962-6968. (Pubitemid 32641583)
22. Pickart CM, Eddins MJ. 2004. Ubiquitin: Structures, functions, mechanisms. Biochem Biophys Acta 1695:55-72.
23. Prosperi MT, Ferbus D, Rouillard D, Goubin G. 1998. The pag gene product, a physiological inhibitor of c-abl tyrosine kinase, is overepressed in cells entering S phase and by contact with agents inducing oxidative stress. FEBS Lett 423:39-44. (Pubitemid 28098575)
24. Rubin CL, Atweh GF. 2004. The role of stathmin in the regulation of the cell cycle. J Cell Biochem 93:242-250. (Pubitemid 44264202)
25. Sells MA, Chen ML. 1987. Acs G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci USA 84:1005-1009.
26. Singer JD, Gurian-West M, Clurman B, Roberts JM. 1999. Cullin-3 targets cyclin E for ubiquitination and controls S phase in mammalian cells. Genes Dev 13:2375-2387. (Pubitemid 29453609)
27. Song H, Xia SL, Liao C, Li YL, Wang YF, Li TP, ZhaoMJ. 2004. Genes encoding Pir51, Beclin1, RbAp48, and aldolase b are up or downregulated in human primary hepatocellular carcinoma. World J Gastroenterol 10:509-513.
28. Tang H, OishiN, Kaneko S, Muakami S. 2006.Molecular functions and biological roles of hepatitis B virus X protein. Cancer Sci 97:977-983. (Pubitemid 44322542)
29. Wang GH, Seeger C. 1993. Novel mechanism for reverse transcription in hepatitis B viruses. J Virol 67:6507-6512. (Pubitemid 23309116)
30. Wittenmayer N, Jandrig B, Rothkegel M, Schlü ter K, Arnold W, Haensch W, Scherneck S, Jockusch BM. 2004. Tumor suppressor activity of profilin requires a functional actin binding site. Mol Biol Cell 15:1600-1608.
31. Yap CT, Simpson TI, Pratt T, Price DJ, Maciver SK. 2005. The motility of glioblastoma tumour cells is modulated by intracellular cofilin expression in a concentration-dependent manner. Cell Motil Cytoskeleton 60:153-165. (Pubitemid 40316155)